Retatrutide Monotherapy in Early Type 2 Diabetes: Glycemic Control and Weight Loss
Retatrutide monotherapy substantially reduced A1C and body weight in early type 2 diabetes, highlighting triple-receptor agonism while leaving comparative effectiveness and long-term outcomes uncertain.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.